Following recent changes in the medical infrastructure in Switzerland, the number of hyperbaric facilities fell from ten to two, and the existing algorithms for telemedical assistance of divers required review. A retrospective study of decompression illness (DCI) from 2004 to 2008 showed that many divers were asymptomatic at the start of hyperbaric treatment. Because of this and recent publications, we may need to modify in the future the decision to recompress a diver. The descriptive nomenclature for DCI was used to determine the probability that symptoms represent DCI. Secondly we evaluated the probability that symptoms may be due to other pathologies or of psychosomatic origin, and thirdly the potential of symptoms for sequelae and their degree of invalidism was estimated. This process will result in one of three therapeutic decisions. An absolute indication for hospital-based hyperbaric treatment. Immediate recompression if available or normobaric oxygen (NBO) with telemedical supervision and adequate monitoring; in exceptional situations, on-site chamber recompression or in-water recompression may be considered. NBO as a preventive measure for two hours and 'bends watch' for 24 h. A prospective study should confirm evidence of good treatment practice. The key for further improvements will be to better understand ambiguous symptoms and to differentiate so-called 'mild' neurological symptoms. As a consequence of the reduction in hyperbaric facilities, longer transfer and treatment delays have resulted. Therefore, there is a need for careful evaluation of the indications for hyperbaric treatment of injured divers and also of the need to install on-site chambers for professional diving operations.

Download full-text PDF

Source

Publication Analysis

Top Keywords

hyperbaric treatment
12
hyperbaric facilities
8
probability symptoms
8
treatment
6
hyperbaric
6
symptoms
5
problems preclinical
4
preclinical treatment
4
treatment algorithm
4
algorithm diving
4

Similar Publications

Hyperbaric Oxygen Therapy (HBOT) is a medical treatment that involves administering 100% oxygen at increased atmospheric pressure to enhance oxygen delivery to tissues. Initially developed for decompression sickness, HBOT has since been utilized for a wide range of medical conditions, including severe infections, non-healing wounds, and, more recently, COVID-19. This review explores the historical development of HBOT, its principles, its emerging role in the management of and its outcome as treatment in COVID-19, particularly in mitigating inflammation, hypoxemia, and oxidative stress.

View Article and Find Full Text PDF

Case report of the successful treatment of pemphigus vulgaris using ovine forestomach matrix graft.

J Surg Case Rep

January 2025

Department of Medical Affairs, Aroa Biosurgery Limited, 64 Richard Pearse Drive, Auckland 2022, New Zealand.

Pemphigus vulgaris (PV) is a subtype of pemphigus and life-altering disorder that results in the formation of intraepithelial blisters in mucosa and skin. Though the etiology is not well understood, it is an autoimmune disorder resulting in acantholytic blisters due to auto-antibodies targeting proteins of keratinocyte adhesion. Rapid diagnosis and restoration of the epidermal layer is imperative for patients with PV as widespread epidermal damage can lead to high morbidity and mortality rates.

View Article and Find Full Text PDF

Blood from septic patients with necrotising soft tissue infection treated with hyperbaric oxygen reveal different gene expression patterns compared to standard treatment.

BMC Med Genomics

January 2025

Department of Anaesthesiology, Centre of Head and Orthopedics, Copenhagen University Hospital, Rigshospitalet, Inge Lehmanns Vej 6, Copenhagen, 2100, Denmark.

Background: Sepsis and shock are common complications of necrotising soft tissue infections (NSTI). Sepsis encompasses different endotypes that are associated with specific immune responses. Hyperbaric oxygen (HBO) treatment activates the cells oxygen sensing mechanisms that are interlinked with inflammatory pathways.

View Article and Find Full Text PDF

Visual Outcomes of Central Retinal Artery Occlusion: Exploring Treatment Strategies Beyond the Conventional Time Window.

J Stroke Cerebrovasc Dis

January 2025

Department of Ophthalmology, Taipei Veterans General Hospital, Taipei, Taiwan, Republic of China; Department of Ophthalmology, School of Medicine, National Yang Ming Chiao Tung University, Taipei, Taiwan, Republic of China. Electronic address:

Backgrounds/aims: Central retinal artery occlusion (CRAO) is a vision-devastating emergency. However, widely-acknowledged treatment consensus is lacking and prehospital delays commonly occur. Hence, we aimed to investigate the visual outcomes of conservative treatments (CT), local intra-arterial fibrinolysis (LIF) and hyperbaric oxygen (HBO) therapy for non-arteritic CRAO (NA-CRAO) patients beyond the conventional time window.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!